Mark Lawler, Chair in Translational Cancer Genomics and the Associate Director of Postgraduate Studies at Queen’s University Belfast, shared a post on X:
“Delighted to announce our ground-breaking €10M PEACEPLUS Digital ONEHEALTH Programme, Queen’s University Belfast, led by Catalyst and with partners.”
Then he shared another post on X, adding:
“ONEHEALTH will deploy the latest AI and digital innovations and platforms to solve the most relevant human, animal and environmental issues in our region, delivering the health dividend of peace and the economic dividend of health”
More posts featuring Mark Lawler on OncoDaily.